Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Parallel Advisors, LLC ownership in GILD / Gilead Sciences, Inc.

On June 2, 2026 - Parallel Advisors, LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Gilead Sciences, Inc. (US:GILD) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 78,474 shares of Gilead Sciences, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-06-02 2026-03-31 13F/A-1 GILEAD SCIENCES Stock 375558103 0 -78,474 -100.00 0 -100.00
2026-02-11 2025-12-31 13F GILEAD SCIENCES Stock 375558103 78,474 4,004 5.38 9,632 16.51 0.1762
2025-11-13 2025-09-30 13F GILEAD SCIENCES Stock 375558103 74,470 39,239 111.38 8,266 111.62 0.1514
2025-07-08 2025-06-30 13F GILEAD SCIENCES Stock 375558103 35,231 1,067 3.12 3,906 2.04 0.0781
2025-04-08 2025-03-31 13F GILEAD SCIENCES Stock 375558103 34,164 -2,876 -7.76 3,828 11.90 0.0863
2025-02-10 2024-12-31 13F GILEAD SCIENCES Stock 375558103 37,040 -2,258 -5.75 3,421 3.86 0.0770
2024-11-13 2024-09-30 13F GILEAD SCIENCES Stock 375558103 39,298 -18,825 -32.39 3,295 -17.38 0.0775
2024-08-08 2024-06-30 13F GILEAD SCIENCES Stock 375558103 58,123 12,349 26.98 3,988 18.94 0.1022
2024-05-06 2024-03-31 13F GILEAD SCIENCES Stock 375558103 45,774 2,438 5.63 3,353 -4.50 0.0909
2024-02-12 2023-12-31 13F GILEAD SCIENCES Stock 375558103 43,336 207 0.48 3,511 8.60 0.1041
2024-05-20 2023-09-30 13F/A-1 GILEAD SCIENCES Stock 375558103 43,129 -1,421 -3.19 3,232 -5.85 0.1077
2023-11-14 2023-09-30 13F GILEAD SCIENCES Stock 375558103 43,129 -1,421 3,232 0.1077
2024-05-20 2023-06-30 13F/A-1 GILEAD SCIENCES Stock 375558103 44,550 404 0.92 3,433 -6.25 0.1106
2023-08-04 2023-06-30 13F GILEAD SCIENCES Stock 375558103 44,550 404 3,433 0.1106
2024-05-20 2023-03-31 13F/A-1 GILEAD SCIENCES Stock 375558103 44,146 1,908 4.52 3,663 0.99 0.1235
2023-04-25 2023-03-31 13F GILEAD SCIENCES Stock 375558103 44,146 1,908 3,663 0.1235
2023-02-06 2022-12-31 13F GILEAD SCIENCES Stock 375558103 42,238 -2,389 -5.35 3,626 31.71 0.1572
2022-11-10 2022-09-30 13F GILEAD SCIENCES Stock 375558103 44,627 7,680 20.79 2,753 20.53 0.1267
2022-08-01 2022-06-30 13F GILEAD SCIENCES Stock 375558103 36,947 1,488 4.20 2,284 7.99 0.1048
2022-04-28 2022-03-31 13F GILEAD SCIENCES Stock 375558103 35,459 2,205 6.63 2,115 -12.42 0.0839
2022-01-20 2021-12-31 13F GILEAD SCIENCES Stock 375558103 33,254 2,255 7.27 2,415 11.55 0.0897
2021-11-02 2021-09-30 13F/A-1 GILEAD SCIENCES Stock 375558103 30,999 1,657 5.65 2,165 7.13 0.0873
2021-08-06 2021-06-30 13F GILEAD SCIENCES Stock 375558103 29,342 2,335 8.65 2,021 15.82 0.0856
2021-04-23 2021-03-31 13F GILEAD SCIENCES Stock 375558103 27,007 821 3.14 1,745 14.35 0.0823
2021-02-02 2020-12-31 13F GILEAD SCIENCES Stock 375558103 26,186 -450 -1.69 1,526 -9.33 0.0828
2020-10-27 2020-09-30 13F GILEAD SCIENCES Stock 375558103 26,636 -1,801 -6.33 1,683 -23.08 0.1041
2020-07-16 2020-06-30 13F GILEAD SCIENCES Stock 375558103 28,437 363 1.29 2,188 4.29 0.1428
2020-04-27 2020-03-31 13F GILEAD SCIENCES Stock 375558103 28,074 3,005 11.99 2,098 28.79 0.1699
2020-01-30 2019-12-31 13F GILEAD SCIENCES Stock 375558103 25,069 -1,276 -4.84 1,629 -2.46 0.1222
2019-11-01 2019-09-30 13F GILEAD SCIENCES Stock 375558103 26,345 150 0.57 1,670 -5.65 0.1430
2019-08-05 2019-06-30 13F GILEAD SCIENCES Stock 375558103 26,195 607 2.37 1,770 6.43 0.1727
2019-05-01 2019-03-31 13F GILEAD SCIENCES Stock 375558103 25,588 -116 -0.45 1,663 3.48 0.1867
2019-02-05 2018-12-31 13F GILEAD SCIENCES Stock 375558103 25,704 -6,138 -19.28 1,607 -34.65 0.2241
2018-11-01 2018-09-30 13F GILEAD SCIENCES Stock 375558103 31,842 25,900 435.88 2,459 485.48 0.3054
2018-07-30 2018-06-30 13F GILEAD SCIENCES Stock 375558103 5,942 -1,173 -16.49 420 -21.64 0.0601
2018-05-08 2018-03-31 13F GILEAD SCIENCES Stock 375558103 7,115 -178 -2.44 536 2.68 0.0837
2018-02-13 2017-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 7,293 208 2.94 522 1.16 0.0854
2017-11-15 2017-09-30 13F/A-1 GILEAD SCIENCES INC COM Stock 375558103 7,085 147 2.12 516 -2.27 0.0887
2017-08-07 2017-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 6,938 2,014 40.90 528 59.52 0.0996
2017-05-12 2017-03-31 13F/A-1 GILEAD SCIENCES INC COM Stock 375558103 4,924 -4,244 -46.29 331 -49.62 0.0658
2017-05-12 2017-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 4,924 331
2017-02-14 2016-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 9,168 9,168 657 0.1543
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F GILEAD SCIENCES Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F GILEAD SCIENCES Stock Call 29,342 2,021 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.